Jan 24th 2013 - Edison Investment Research today published a report on Deltex Medical (DEMG.L, LSE:DEMG, LON:DEMG) entitled "Saving Over $5,000 Per US Patient". In summary, the report says:
Premier study data on enhanced recovery using CardioQ showed a saving of over $5,000 per patient from substantial falls in mean stay time and intensive care use. Readmissions reduced by over 50% during the 90 days after surgery. This data enables a five hospital implementation study which Deltex will part-fund at a net cost of £2.5m. Once this reports in H115, it will give a springboard for US growth; up to 335 large hospitals may adopt the package. In the UK the new NHS target is for 80,000 annualised uses from April 2014; if achieved, this implies steady 2013 growth and a doubling in sales in 2015. Sales in 2012 were £6.8m, up 8%, cash was £0.7m.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »